Skip to content

Insider · CIK 0001091823

KIRK RANDAL J

Reports to the SEC for 13 companies · RADFORD, VA

Transactions

50

Companies

13

Filings

4

CIK

0001091823

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-03-30PGENPRECIGEN, INC.S Sale−$155K
2026-03-30PGENPRECIGEN, INC.S Sale−$78.5K
2026-03-30PGENPRECIGEN, INC.S Sale−$557K
2026-03-30PGENPRECIGEN, INC.S Sale−$129K
2026-03-30PGENPRECIGEN, INC.S Sale−$3.66M
2026-03-30PGENPRECIGEN, INC.S Sale−$168K
2026-03-30PGENPRECIGEN, INC.S Sale−$1.22M
2026-03-30PGENPRECIGEN, INC.S Sale−$502K
2026-03-30PGENPRECIGEN, INC.S Sale−$7.7M
2026-03-30PGENPRECIGEN, INC.S Sale−$168K
2026-03-30PGENPRECIGEN, INC.S Sale−$1.41M
2026-03-13PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion—
2026-03-13PGENPRECIGEN, INC.M Exercise/Conversion—
2026-03-10PGENPRECIGEN, INC. · Restricted Stock UnitsA Award—
2026-03-10PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award—
2026-03-10PGENPRECIGEN, INC.A Award+$100K
2025-12-22PGENPRECIGEN, INC.S Sale−$394K
2025-12-22PGENPRECIGEN, INC.S Sale−$2.32M
2025-12-22PGENPRECIGEN, INC.S Sale−$54K
2025-12-22PGENPRECIGEN, INC.S Sale−$4M
2025-12-22PGENPRECIGEN, INC.S Sale−$24.9K
2025-12-22PGENPRECIGEN, INC.S Sale−$41.5K
2025-12-22PGENPRECIGEN, INC.S Sale−$49.8K
2025-12-22PGENPRECIGEN, INC.S Sale−$178K
2025-12-22PGENPRECIGEN, INC.S Sale−$666K
2025-12-22PGENPRECIGEN, INC.S Sale−$54K
2025-12-22PGENPRECIGEN, INC.S Sale−$162K
2025-11-21PGENPRECIGEN, INC.S Sale−$3.59M
2025-11-20PGENPRECIGEN, INC.S Sale−$3.85M
2025-11-19PGENPRECIGEN, INC.S Sale−$4.86M
2025-09-30PGENPRECIGEN, INC.S Sale−$6.17M
2025-09-19PGENPRECIGEN, INC.S Sale−$13.2M
2025-09-18PGENPRECIGEN, INC.S Sale−$5.42M
2025-09-17PGENPRECIGEN, INC. · 8.00% Series A Convertible Perpetual Preferred StockM Exercise/Conversion—
2025-09-17PGENPRECIGEN, INC.M Exercise/Conversion—
2025-03-14PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion—
2025-03-14PGENPRECIGEN, INC.M Exercise/Conversion—
2025-03-13PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award—
2025-03-13PGENPRECIGEN, INC. · Restricted Stock UnitsA Award—
2025-03-13PGENPRECIGEN, INC.A Award+$100K
2024-12-30PGENPRECIGEN, INC. · Warrant to Purchase Common StockP Purchase—
2024-12-30PGENPRECIGEN, INC. · 8.00% Series A Convertible Perpetual Preferred StockP Purchase—
2024-08-09PGENPRECIGEN, INC.P Purchase+$20M
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—
2024-05-02PGENPRECIGEN, INC.J Other—